What is NDC 59651-617?

59651-617 is the product NDC for Rufinamide, Rufinamide 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rufinamide?

20 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rufinamide NDC 59651-617 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-617Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0617Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-617-08	59651061708	120 TABLET, FILM COATED in 1 BOTTLE (59651-617-08)Marketed from Jun 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rufinamide
Generic name (nonproprietary): rufinamide
Active ingredients: Rufinamide — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217230
Marketing start: Jun 16, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 59651-617_96d61d77-4de0-4c57-997d-014010177a86SPL ID 96d61d77-4de0-4c57-997d-014010177a86SPL set ID d9ffc833-d902-41cb-8e8e-6bbba8e65b9eRxCUI 824295, 824301UNII WFW942PR79UPC 0359651616086

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651061708 followed by a unit qualifier and the quantity

Package 59651-0617-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 19, 2025.

Indications (excerpt from the label)

Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-617

What is NDC 59651-617?: 59651-617 is the product NDC for Rufinamide, Rufinamide 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rufinamide.
What is the active ingredient?: Rufinamide.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rufinamide?: 20 other product NDCs are listed under this name. See all Rufinamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rufinamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rufinamide	Rufinamide 40 mg/mL	SuspensionOral	American Health Packaging	60687-824	60687-0824-08
Rufinamide	Rufinamide 40 mg/mL	SuspensionOral	Novadoz Pharmaceuticals LLC	72205-038	72205-0038-77
Rufinamide	Rufinamide 40 mg/mL	SuspensionOral	NorthStar RxLLC	72603-261	72603-0261-01
Rufinamide	Rufinamide 40 mg/mL	SuspensionOral	Camber Pharmaceuticals, Inc.	31722-688	31722-0688-46
Rufinamide	Rufinamide 400 mg/1	TabletOral	Micro Labs Limited	42571-392	42571-0392-12
Rufinamide	Rufinamide 200 mg/1	TabletOral	Micro Labs Limited	42571-391	42571-0391-12
Rufinamide	Rufinamide 40 mg/mL	SuspensionOral	Lupin Pharmaceuticals, Inc.	68180-797	68180-0797-01
Rufinamide	Rufinamide 200 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-616	59651-0616-08
Rufinamide	Rufinamide 200 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-803	68180-0803-16
Rufinamide	Rufinamide 400 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-804	68180-0804-16

All 21 Rufinamide NDCs

Other NDCs under ANDA 217230

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217230
Product	Strength	Form · route	Labeler	Product NDC
Rufinamide	Rufinamide 200 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-616